香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 佈 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不會就因本公佈全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公佈僅供參考，並不構成收購、購買或認購本公司任何證券之邀請或要約。 中福易購計劃通過3 – 5年時間，聚集萬業聯盟，形成1.0階段的商家聯盟生態，構 建「數字化、產業化、集群化、資本化」的數字生活服務體系；通過3 – 5年規劃， 打造集團生態自有矩陣和行業品牌連鎖及供應鏈全鏈端體系的融合，形成2.0階段 的產業規範化集群和資本賦能的品牌生態；經過5 – 10年沉澱與產業生態融合，數 字 化區 塊鏈 底層 邏輯 全面 助力 產消 融+ 商業 創新 ，構 造品 牌連 鎖網 格化 、行 業整 合條線化、自有生態全球化、產業資本矩陣化、上市集群規模化，最終呈現全球 數字生活商業領域領先的服務生態。 AOM INTERNATIONAL GROUP COMPANY LIMITED 權 識 國 際 集 團 股 份 有 限 公 司 （於開曼群島註冊成立 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 佈 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不會就因本公佈全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公佈僅供參考，並不構成收購、購買或認購本公司任何證券之邀請或要約。 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：00381） AOM INTERNATIONAL GROUP COMPANY LIMITED 委任亞太區聯席主席 權 識 國 際 集 團 股 份 有 限 公 司 委任亞太區聯席主席 權識國際集團股份有限公司（「本公司」）及其附屬公司（ 統稱「本集團」）之董事（「董 事」）會（「董事會」）謹此宣佈： 李舜輝先生（「李先生」）已獲委任為亞太區聯席主席，自二零二五年十月二十七日 起生效。 李舜輝的簡歷載列如下： 楊鈴 香港，二零二五年十月二十七日 – 1 – 技 術 獎 ， 產品 出 口 至 日 韓 及 東 南 亞， 年 產 值 超 8 億 元 。 二 零 一 七 年 進軍 互 聯 網 領 域 ， 投 資 秒音 科 ...

Core Insights - *ST Chuntian reported a total operating revenue of 213 million yuan as of September 30, 2025 [1] - The company recorded a net profit attributable to shareholders of -2.83 million yuan as of September 30, 2025 [1] - Operating cash flow showed a net outflow of 68.92 million yuan, a decrease of 88.37 million yuan compared to the same period last year, representing a year-on-year decline of 454.20% [1] Financial Ratios - The latest debt-to-asset ratio for *ST Chuntian is 4.20% as of September 30, 2025 [3] - The gross profit margin is 47.52%, which is a decrease of 13.89 percentage points from the previous quarter [4] - The return on equity (ROE) stands at -0.28% as of September 30, 2025 [4] - The diluted earnings per share (EPS) is -0.01 yuan [4] - The total asset turnover ratio is 0.19 times [4] - The inventory turnover ratio is 0.68 times [4] Shareholder Information - The number of shareholders is 26,500, with the top ten shareholders holding a total of 295 million shares, accounting for 50.24% of the total share capital [4] - The largest shareholder is Tibet Rong'en Technology Co., Ltd., holding 32.1% of the shares [4]

Core Viewpoint - *ST Chuntian (600381.SH) reported a revenue of 213 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 7.32% [1] Financial Performance - The net loss attributable to shareholders of the listed company was 2.83 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 5.89 million yuan [1] - The basic loss per share was 0.005 yuan [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 FF301 FF301 II. 已發行股份及/或庫存股份變動 致：香港交易及結算所有限公司 公司名稱: 權識國際集團股份有限公司 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00381 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 19,860,570,307 | HKD | | 0.1 | HKD | | 1,986,057,030.7 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 19,860,570,307 | HK ...

30 September 2025 AOM International Group Company Limited (the "Company") AOM INTERNATIONAL GROUP COMPANY LIMITED 權識國際集團股份有限公司 (incorporated in the Cayman Islands with limited liability and continued in Bermuda with limited liability) （於開曼群島註冊成立並於百慕達存續之有限公司） (Stock Code 股份代號：00381) NOTIFICATION LETTER 通知信函 Dear Non-registered Holder, - Notification of publication of 2025 Interim Report (" Current Corporate Communications") The Current Corporate Communication of the Company, in both English and Chinese versi ...

AOM INTERNATIONAL GROUP COMPANY LIMITED 僑 雄 國 際 控 股 有 限 公 司 (incorporated in the Cayman Islands with limited liability and continued in Bermuda with limited liability) （於開曼群島註冊成立並於百慕達存續之有限公司） (Stock Code 股份代號：00381) NOTIFICATION LETTER 通知信函 Dear Registered Shareholders, 30 September 2025 AOM International Group Company Limited (the "Company") - Notification of publication of 2025 Interim Report (" Current Corporate Communications") We hereby notify you that the Current Corporate Communication(s) in both Eng ...

Financial Performance - The group recorded a revenue of approximately HKD 203.3 million for the six months ended June 30, 2025, representing an increase of about 41.7% compared to HKD 143.4 million in the same period last year[6]. - The loss attributable to equity holders of the company was approximately HKD 6 million, a decrease from a profit of HKD 17.6 million in the previous year, primarily due to losses from investments in associates[6]. - Revenue for the six months ended June 30, 2025, was HKD 203,267,000, compared to HKD 143,434,000 for the same period in 2024, representing an increase of 41.7%[33]. - Gross profit for the six months ended June 30, 2025, was HKD 63,491,000, down from HKD 69,054,000 in 2024, indicating a decrease of 8.3%[33]. - Net profit for the six months ended June 30, 2025, was HKD 6,733,000, a significant decline from HKD 30,277,000 in 2024, reflecting a decrease of 77.8%[35]. - The total comprehensive income for the six months ended June 30, 2025, was HKD 16,391,000, compared to HKD 19,357,000 in 2024, showing a decrease of 15.3%[35]. - The company reported a total loss of HKD 6,733,000 for the period, a significant decrease from a profit of HKD 30,277,000 in the same period last year[52]. Segment Performance - The toy and gift manufacturing and sales segment generated revenue of approximately HKD 82.3 million, with a gross margin of 57.8%, up from 42.2% in the previous year[8]. - The Chinese herbal medicine business recorded revenue of approximately HKD 42.4 million, down from HKD 57 million in the previous year[9]. - The wine business, acquired on June 5, 2024, generated revenue of approximately HKD 78.6 million, with a segment profit of approximately HKD 2.65 million[10]. - The profit from the toy and gift segment was HKD 1,313,000, compared to a loss of HKD 670,000 in the previous year, indicating a turnaround in performance[52]. - The herbal medicine segment reported a profit of HKD 16,652,000, down from HKD 25,081,000 in the prior year, reflecting a decrease of about 33.3%[52]. - The herbal medicine trading segment generated revenue of HKD 42,356,000, down from HKD 56,950,000 in the previous year, a decline of approximately 25.7%[52]. Financial Position - As of June 30, 2025, the group's cash and bank balances were approximately HKD 117 million, down from HKD 135.9 million as of December 31, 2024[19]. - The group's borrowings amounted to approximately HKD 160.2 million as of June 30, 2025, compared to HKD 139.4 million as of December 31, 2024, indicating an increase in debt[19]. - The capital debt ratio increased to 76% as of June 30, 2025, from 68% as of December 31, 2024, reflecting a higher level of leverage[20]. - The company has a net current liability of approximately HKD 54,803,000 as of June 30, 2025, raising concerns about its ability to continue as a going concern[45]. - The company reported a significant increase in inventory, which rose to HKD 139,761,000 as of June 30, 2025, from HKD 97,643,000 in 2024, an increase of 42.9%[37]. - Total assets as of June 30, 2025, reached HKD 843,875,000, an increase from HKD 796,611,000 as of December 31, 2024, representing a growth of approximately 5.9%[53]. - Total liabilities as of June 30, 2025, amounted to HKD 443,835,000, compared to HKD 412,962,000 as of December 31, 2024, indicating an increase of about 7.5%[54]. Cash Flow and Financing - The financing activities generated a net cash inflow of HKD 18,052,000 for the six months ended June 30, 2025, compared to HKD 38,716,000 in 2024, a decrease of 53.3%[42]. - The company issued 470,000,000 new shares, raising HKD 47,000,000 as part of its capital increase strategy[66]. - The company completed a placement of 470,000,000 ordinary shares at a price of HKD 0.111 per share, netting approximately HKD 51,300,000 after expenses, to repay outstanding convertible bonds[73]. - The company conditionally agreed to issue 157,800,000 subscription shares at a subscription price of approximately HKD 0.4309 per share, with a total subscription amount of approximately HKD 68,000,000[76]. Governance and Compliance - The independent non-executive directors were unable to attend the annual general meeting held on June 18, 2025, due to personal matters, which may impact governance perceptions[26]. - The company has adopted the standard code for securities transactions by directors, confirming compliance during the reporting period[27]. Employee and Operational Metrics - The group employed 368 staff as of June 30, 2025, an increase from 365 employees as of December 31, 2024, indicating a slight growth in workforce[24]. - Employee costs, including directors' remuneration, totaled HKD 22,896,000 for the six months ended June 30, 2025, up from HKD 21,914,000 in 2024, reflecting an increase of approximately 4.5%[58].

Group 1 - The stock of Quan Shi International (00381.HK) increased by over 10% on September 19, reaching a rise of 11.39% to HKD 0.44 [1] - The trading volume for Quan Shi International was reported at HKD 1.5068 million [1]

Group 1 - The core point of the article is that Quan Shi International (00381) has seen its stock price increase by over 10%, specifically by 11.39%, reaching HKD 0.44, with a trading volume of HKD 1.5068 million [1] - The company has announced a memorandum of understanding with Ms. Wang Fang (the seller) to negotiate a potential conditional acquisition of 51% equity in Hainan Miao Lian Technology Co., Ltd. (the target company) [1] - Hainan Miao Lian Technology Co., Ltd., established in 2021, is a specialized provider of digital solutions for enterprises, covering various aspects of digitalization including strategic planning, business process optimization, data mining, machine learning, cloud computing, and big data [1]